639 related articles for article (PubMed ID: 34145351)
1. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis.
Prakash A; Singh H; Sarma P; Bhattacharyya A; Dhibar DP; Balaini N; Shree R; Goyal M; Modi M; Medhi B
Sci Rep; 2021 Jun; 11(1):12888. PubMed ID: 34145351
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.
Rogers JP; Chesney E; Oliver D; Pollak TA; McGuire P; Fusar-Poli P; Zandi MS; Lewis G; David AS
Lancet Psychiatry; 2020 Jul; 7(7):611-627. PubMed ID: 32437679
[TBL] [Abstract][Full Text] [Related]
3. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
4. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.
Di Mascio D; Khalil A; Saccone G; Rizzo G; Buca D; Liberati M; Vecchiet J; Nappi L; Scambia G; Berghella V; D'Antonio F
Am J Obstet Gynecol MFM; 2020 May; 2(2):100107. PubMed ID: 32292902
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
Javed A
CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
[TBL] [Abstract][Full Text] [Related]
7. Update on neurological manifestations of COVID-19.
Yavarpour-Bali H; Ghasemi-Kasman M
Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis.
Wang L; Shen Y; Li M; Chuang H; Ye Y; Zhao H; Wang H
J Neurol; 2020 Oct; 267(10):2777-2789. PubMed ID: 32529575
[TBL] [Abstract][Full Text] [Related]
9. Neurological manifestations in patients with COVID-19: A systematic review and meta-analysis.
Mahdizade Ari M; Mohamadi MH; Shadab Mehr N; Abbasimoghaddam S; Shekartabar A; Heidary M; Khoshnood S
J Clin Lab Anal; 2022 May; 36(5):e24403. PubMed ID: 35385200
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of depression during the SARS, MERS, and COVID-19 pandemics: A protocol for overview of systematic reviews.
Du L; Chen YM; Li Y; Yuan W; Wang JS
Medicine (Baltimore); 2020 Sep; 99(38):e22235. PubMed ID: 32957366
[TBL] [Abstract][Full Text] [Related]
11. Neurological associations of COVID-19.
Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
[TBL] [Abstract][Full Text] [Related]
12. Neurological manifestations of COVID-19, SARS and MERS.
Verstrepen K; Baisier L; De Cauwer H
Acta Neurol Belg; 2020 Oct; 120(5):1051-1060. PubMed ID: 32562214
[TBL] [Abstract][Full Text] [Related]
13. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
Bostancıklıoğlu M
Inflamm Bowel Dis; 2020 Jul; 26(8):e89-e91. PubMed ID: 32440692
[TBL] [Abstract][Full Text] [Related]
14. COVID-19, SARS and MERS: A neurological perspective.
Ng Kee Kwong KC; Mehta PR; Shukla G; Mehta AR
J Clin Neurosci; 2020 Jul; 77():13-16. PubMed ID: 32417124
[TBL] [Abstract][Full Text] [Related]
15. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences.
Lahiri D; Mondal R; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Biswas SC
Diabetes Metab Syndr; 2020; 14(5):1053-1060. PubMed ID: 32640417
[TBL] [Abstract][Full Text] [Related]
16. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions.
Favas TT; Dev P; Chaurasia RN; Chakravarty K; Mishra R; Joshi D; Mishra VN; Kumar A; Singh VK; Pandey M; Pathak A
Neurol Sci; 2020 Dec; 41(12):3437-3470. PubMed ID: 33089477
[TBL] [Abstract][Full Text] [Related]
17. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
18. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.
Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH;
Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).
Payus AO; Liew Sat Lin C; Mohd Noh M; Jeffree MS; Ali RA
Bosn J Basic Med Sci; 2020 Aug; 20(3):283-292. PubMed ID: 32530389
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Cardiovascular Comorbidities in Coronavirus Disease 2019, Severe Acute Respiratory Syndrome, and Middle East Respiratory Syndrome: Pooled Analysis of Published Data.
Liu Y; Wu S; Qin M; Jiang W; Liu X
J Am Heart Assoc; 2020 Sep; 9(17):e016812. PubMed ID: 32673529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
